VistaGen Therapeutics, Inc. (VTGN) Ownership

$3.65

north_east
$0.05 (1.39%)
Day's range
$3.48
Day's range
$3.71

VistaGen Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 11/14/2025 4.17 M $14.75 M   100.00% 13.05%
ORBIMED ADVISORS LLC 11/14/2025 3.06 M $10.86 M   100.00% 9.58%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 2.68 M $9.50 M   0.00% 8.38%
STEMPOINT CAPITAL LP 11/14/2025 2.49 M $7.75 M   3.13% 7.79%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 1.98 M $7.02 M   0.00% 6.20%
VANGUARD GROUP INC 11/07/2025 1.69 M $5.99 M   -4.09% 5.29%
COMMODORE CAPITAL LP 11/14/2025 1.58 M $5.59 M   0.00% 4.93%
IKARIAN CAPITAL, LLC 11/14/2025 620.87 K $2.20 M   3.19% 1.94%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 550.00 K $1.95 M   100.00% 1.72%
BLACKROCK, INC. 11/12/2025 423.13 K $1.50 M   1.50% 1.33%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 422.01 K $1.50 M   942.00% 1.32%
DIADEMA PARTNERS LP 11/14/2025 349.79 K $1.24 M   -13.40% 1.10%
JANE STREET GROUP, LLC 11/14/2025 302.68 K $1.07 M   218.44% 0.95%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 298.28 K $1.06 M   9.30% 0.93%
TWO SIGMA INVESTMENTS, LP 11/14/2025 289.41 K $1.03 M   223.54% 0.91%
JPMORGAN CHASE & CO 11/26/2025 271.83 K $964.98 K   -63.70% 0.85%
ALMITAS CAPITAL LLC 11/17/2025 261.40 K $927.97 K   0.00% 0.82%
CITADEL ADVISORS LLC 11/14/2025 242.60 K $861.23 K   261.55% 0.76%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 231.30 K $821.12 K   100.00% 0.72%
ADVISORSHARES INVESTMENTS LLC 11/05/2025 207.00 K $734.84 K   1.91% 0.65%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2025 197.02 K $699.44 K   10.78% 0.62%
TWO SIGMA ADVISERS, LP 11/14/2025 157.03 K $557.46 K   507.90% 0.49%
BML CAPITAL MANAGEMENT, LLC 11/10/2025 150.00 K $532.50 K   0.00% 0.47%
CITADEL ADVISORS LLC 11/14/2025 122.06 K $433.32 K   100.00% 0.38%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2025 113.06 K $401.37 K   -73.13% 0.35%
DIADEMA PARTNERS LP 11/14/2025 100.20 K $355.71 K   50,000.00% 0.31%
CITADEL ADVISORS LLC 11/14/2025 99.50 K $353.23 K   177.16% 0.31%
STATE STREET CORP 11/14/2025 96.86 K $343.85 K   0.00% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 85.59 K $303.86 K   -25.81% 0.27%
PERSISTENT ASSET PARTNERS LTD 11/10/2025 75.32 K $267.38 K   -13.25% 0.24%
XTX TOPCO LTD 11/14/2025 69.71 K $247.48 K   100.00% 0.22%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 68.02 K $241.40 K   56.86% 0.21%
WALLEYE CAPITAL LLC 11/14/2025 67.77 K $240.58 K   100.00% 0.21%
GOLDMAN SACHS GROUP INC 11/14/2025 60.15 K $213.54 K   100.00% 0.19%
NORTHERN TRUST CORP 11/14/2025 48.09 K $170.73 K   0.00% 0.15%
ORBIMED ADVISORS LLC 11/14/2025 45.20 K $160.46 K   100.00% 0.14%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 43.95 K $156.03 K   100.00% 0.14%
OCCUDO QUANTITATIVE STRATEGIES LP 11/14/2025 42.70 K $151.60 K   100.00% 0.13%
AMERICAN CENTURY COMPANIES INC 11/12/2025 41.07 K $145.81 K   32.22% 0.13%
BANK OF AMERICA CORP /DE/ 11/14/2025 34.66 K $123.03 K   925.96% 0.11%
GSA CAPITAL PARTNERS LLP 11/07/2025 31.49 K $112.00 K   100.00% 0.10%
GROUP ONE TRADING, L.P. 11/12/2025 28.93 K $102.69 K   305.04% 0.09%
MORGAN STANLEY 11/14/2025 27.53 K $97.75 K   126.67% 0.09%
UBS GROUP AG 11/13/2025 25.67 K $91.12 K   12.51% 0.08%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 23.30 K $82.72 K   0.00% 0.07%
HIGHTOWER ADVISORS, LLC 11/07/2025 20.83 K $73.94 K   0.00% 0.07%
MILLENNIUM MANAGEMENT LLC 11/14/2025 20.68 K $73.40 K   100.00% 0.06%
KESTRA ADVISORY SERVICES, LLC 11/14/2025 20.03 K $71.12 K   0.00% 0.06%
QUADRATURE CAPITAL LTD 11/13/2025 15.75 K $55.76 K   100.00% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 14.50 K $51.48 K   100.00% 0.05%

VistaGen Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 73 institutional investors and hedge funds held shares of VistaGen Therapeutics, Inc.. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 4.17 M

ORBIMED ADVISORS LLC: 3.06 M

TCG Crossover Management, LLC: 2.68 M

StemPoint Capital LP: 2.49 M

Nantahala Capital Management, LLC: 1.98 M

VANGUARD GROUP INC: 1.69 M

73.15% of VistaGen Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 24.17 M shares in the last 24 months. This purchase volume represents approximately $88.23 M in transactions.